GB Patent

GB2474930A — Topical composition comprising a tetracycline

Assigned to Foamix Ltd · Expires 2011-05-04 · 15y expired

What this patent protects

A topical therapeutic hydrophobic breakable composition comprises a carrier, which includes: (a) about 60% to about 99% by weight of at least one hydrophobic oil; (b) at least one viscosity-modifying agent selected from the group consisting of a fatty alcohol, a fatty acid and a …

USPTO Abstract

A topical therapeutic hydrophobic breakable composition comprises a carrier, which includes: (a) about 60% to about 99% by weight of at least one hydrophobic oil; (b) at least one viscosity-modifying agent selected from the group consisting of a fatty alcohol, a fatty acid and a wax; and (c) a tetracycline antibiotic. The viscosity of the composition is at least about 30% higher than the viscosity of the carrier without the tetracycline antibiotic; and is higher than the viscosity of the hydrophobic oil and the tetracycline antibiotic without the viscosity modifying agents. The tetracycline is chemically stable in the composition for at least six months; wherein more than about 90% of the tetracycline has not broken down. When packaged in an aerosol container, the composition affords upon release from the container a breakable foam of at least good quality that breaks easily upon application of shear force.

Drugs covered by this patent

Patent Metadata

Patent number
GB2474930A
Jurisdiction
GB
Classification
Expires
2011-05-04
Drug substance claim
No
Drug product claim
No
Assignee
Foamix Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.